Robin A. Karol

1.2k total citations
19 papers, 811 citations indexed

About

Robin A. Karol is a scholar working on Molecular Biology, Safety, Risk, Reliability and Quality and Strategy and Management. According to data from OpenAlex, Robin A. Karol has authored 19 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Safety, Risk, Reliability and Quality and 3 papers in Strategy and Management. Recurrent topics in Robin A. Karol's work include Technology Assessment and Management (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Blood groups and transfusion (3 papers). Robin A. Karol is often cited by papers focused on Technology Assessment and Management (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Blood groups and transfusion (3 papers). Robin A. Karol collaborates with scholars based in United States, Germany and Japan. Robin A. Karol's co-authors include Jeffrey M. Davidson, Aleksandar G. Slavejkov, Michael J. Incorvia, Albert L. Johnson, Peter A. Koen, Klaus W. Wagner, Donald M. Marcus, S K Kundu, Robert W. Noble and Morris Reichlin and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and International Journal of Cancer.

In The Last Decade

Robin A. Karol

19 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin A. Karol United States 11 361 207 123 106 98 19 811
Geciâne Silveira Porto Brazil 17 270 0.7× 168 0.8× 94 0.8× 58 0.5× 30 0.3× 95 789
George Scott United States 16 122 0.3× 62 0.3× 96 0.8× 58 0.5× 202 2.1× 43 1.2k
Deepak K. Sinha India 17 203 0.6× 59 0.3× 254 2.1× 40 0.4× 17 0.2× 54 1.0k
Tom Williams United States 12 160 0.4× 49 0.2× 214 1.7× 412 3.9× 273 2.8× 14 1.1k
Heinz‐Theo Wagner Germany 21 464 1.3× 189 0.9× 144 1.2× 100 0.9× 345 3.5× 109 1.8k
Christian Clausen Denmark 19 155 0.4× 127 0.6× 264 2.1× 38 0.4× 21 0.2× 77 1.1k
Maria Raquel da Costa Pinto Brazil 9 176 0.5× 73 0.4× 35 0.3× 89 0.8× 19 0.2× 21 611
Lindgren United States 4 168 0.5× 159 0.8× 259 2.1× 129 1.2× 60 0.6× 9 1.3k
Carsten Zimmermann United States 10 313 0.9× 83 0.4× 228 1.9× 85 0.8× 72 0.7× 18 1.1k
Yanlu Zhang China 19 166 0.5× 69 0.3× 153 1.2× 105 1.0× 219 2.2× 55 1.4k

Countries citing papers authored by Robin A. Karol

Since Specialization
Citations

This map shows the geographic impact of Robin A. Karol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin A. Karol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin A. Karol more than expected).

Fields of papers citing papers by Robin A. Karol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin A. Karol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin A. Karol. The network helps show where Robin A. Karol may publish in the future.

Co-authorship network of co-authors of Robin A. Karol

This figure shows the co-authorship network connecting the top 25 collaborators of Robin A. Karol. A scholar is included among the top collaborators of Robin A. Karol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin A. Karol. Robin A. Karol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Karol, Robin A.. (2015). Leadership in the Context of Corporate Entrepreneurship. Journal of Leadership Studies. 8(4). 30–34. 30 indexed citations
2.
Karol, Robin A., et al.. (2007). New Product Development for Dummies. Medical Entomology and Zoology. 1 indexed citations
3.
Karol, Robin A., et al.. (2002). Better New Business Development DuPont-II: A "Business Initiative Process" Provides Teams and Their Leaders with Frameworks and Tools to Support the Application of Judgment and Learning to Their NPD Projects. Research-Technology Management. 45(2). 47. 6 indexed citations
4.
Karol, Robin A., et al.. (2002). Better New Business Development at DuPont—II. Research-Technology Management. 45(2). 47–56. 8 indexed citations
5.
Karol, Robin A., et al.. (2002). Better New Business Development at DuPont—I. Research-Technology Management. 45(1). 24–30. 14 indexed citations
6.
Koen, Peter A., Jeffrey M. Davidson, Michael J. Incorvia, et al.. (2001). PROVIDING CLARITY AND A COMMON LANGUAGE TO THE "FUZZY FRONT END" Eight companies collectively determined a theoretical construct for the Fuzzy Front End of innovation in order to provide a common framework and language; they found that highly innovative companies have a more proficient FFE.. 1 indexed citations
7.
Koen, Peter A., Jeffrey M. Davidson, Michael J. Incorvia, et al.. (2001). Providing Clarity and A Common Language to the “Fuzzy Front End”. Research-Technology Management. 44(2). 46–55. 496 indexed citations
8.
Davidson, Jeffrey M., et al.. (1999). Learning from the Best New Product Developers. Research-Technology Management. 42(4). 12–18. 25 indexed citations
9.
Wong, Pancras C., Thomas M. Reilly, Robin A. Karol, & Pieter B.M.W.M. Timmermans. (1987). Functional antagonism by monoclonal antibody to digoxin in the guinea-pig atria. European Journal of Pharmacology. 136(3). 437–440. 4 indexed citations
10.
Karol, Robin A., et al.. (1984). Hereditary abnormalities of the OKT4 human lymphocyte epitope in two families. Journal of Clinical Immunology. 4(1). 71–74. 20 indexed citations
11.
Lawrence, E. Clinton, et al.. (1984). Immunoregulation in an Isolated 12-year-old Boy with Congenital Severe Combined Immunodeficiency. Pediatric Research. 18(8). 723–728. 8 indexed citations
12.
Karol, Robin A., James B. Cooper, David Dennison, et al.. (1983). Imbalances in subsets of T lymphocytes in an inbred pedigree with Omenn's syndrome. Clinical Immunology and Immunopathology. 27(3). 412–427. 20 indexed citations
13.
Willison, Keith R., Robin A. Karol, Akiko Suzuki, S K Kundu, & Donald M. Marcus. (1982). Neutral glycolipid antigens as developmental markers of mouse teratocarcinoma and early embryos: an immunologic and chemical analysis.. The Journal of Immunology. 129(2). 603–609. 82 indexed citations
14.
Suzuki, Akemi, Robin A. Karol, Samar K. Kundu, & Donald M. Marcus. (1981). Glycosphingolipids of K562 cells: A chemical and immunological analysis. International Journal of Cancer. 28(3). 271–276. 23 indexed citations
15.
Karol, Robin A., S K Kundu, & Donald M. Marcus. (1981). Immunochemical Relationship Between Forssman and Globoside Glycolipid Antigens. Immunological Communications. 10(3). 237–250. 12 indexed citations
16.
Karol, Robin A., et al.. (1980). Immunological reactivity and concentration of glycosphingolipids in adult and umbilical cord erythrocytes. Revue Franç aise de Transfusion et Immuno-hé matologie. 23(5). 589–598. 3 indexed citations
17.
Karol, Robin A., et al.. (1978). Specific Antibodies to Hemoglobin A1 (anti-Glu) and Hemoglobin S (anti-Val) in the Guinea Pig: Immunologic and Structural Correlations. The Journal of Immunology. 121(6). 2458–2462. 3 indexed citations
18.
Karol, Robin A., Morris Reichlin, & Robert W. Noble. (1978). Idiotypic cross-reactivity between antibodies of different specificities.. The Journal of Experimental Medicine. 148(6). 1488–1497. 36 indexed citations
19.
Karol, Robin A., Morris Reichlin, & Robert W. Noble. (1977). Evolution of an idiotypic determinant: anti-Val.. The Journal of Experimental Medicine. 146(2). 435–444. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geciâne Silveira Porto Breakdown of academic impact, for papers by George Scott Breakdown of academic impact, for papers by Deepak K. Sinha Breakdown of academic impact, for papers by Tom Williams Breakdown of academic impact, for papers by Heinz‐Theo Wagner Breakdown of academic impact, for papers by Christian Clausen Breakdown of academic impact, for papers by Maria Raquel da Costa Pinto Breakdown of academic impact, for papers by Lindgren Breakdown of academic impact, for papers by Carsten Zimmermann Breakdown of academic impact, for papers by Yanlu Zhang
Rankless by CCL
2026